What Is Mycoprotein? Nutrition, Safety, and Production

Mycoprotein is protein derived from fungi, most commonly the filamentous mold Fusarium venenatum, grown through continuous fermentation in large bioreactors. It has been sold commercially since the 1980s, primarily under the Quorn brand, and sits in a category distinct from both plant proteins and cultured meat. What makes mycoprotein unusual among alternative proteins is the naturally fibrous structure of fungal hyphae, which gives it a texture closer to chicken or beef than most soy or pea-based products can manage. The science around it has expanded considerably in the last few years, with research covering everything from muscle-building to cholesterol reduction to greenhouse gas footprints.

How Mycoprotein Is Produced

The core process is aerobic fermentation. Fusarium venenatum is fed a glucose-based substrate (historically derived from wheat starch) inside large airlift bioreactors, where it grows continuously in a liquid medium. The fungus naturally forms long, branching filaments called hyphae. When those filaments are harvested, heated to reduce RNA content, and then mixed with a binding agent like egg albumen, the result is a pale, dough-like paste. Forming, cooking, and controlled freezing cause the filaments to align into a fiber-gel composite that mimics the layered, chewy quality of animal muscle tissue.

The RNA reduction step matters. Like all rapidly growing microorganisms, Fusarium venenatum produces nucleic acids at levels that would be problematic for human consumption. A brief heat treatment breaks down excess RNA before the biomass is processed into food. The continuous-flow fermentation setup can run for weeks at a time, with fresh substrate fed in and harvested biomass drawn off, which is a key reason production can scale.

Nutritional Profile

Mycoprotein checks several boxes that nutrition researchers care about. It is high in protein and fiber while being low in fat, cholesterol, sodium, and sugar.² The fiber is primarily beta-glucan and chitin from the fungal cell walls, which sets it apart from most animal and plant protein sources. A serving of mycoprotein delivers around 11 grams of protein alongside roughly 6 grams of fiber, though exact figures vary by product formulation.

Protein quality assessments put mycoprotein in good company. Using the DIAAS scoring system, which measures how well the body can digest and use a protein’s amino acids, mycoprotein ranks alongside soy and certain insect proteins as a high-quality source. Animal proteins still score higher on average, but mycoprotein sits well above most cereal and legume proteins.³

On the mineral front, mycoprotein-based products tend to be rich in zinc and have very low phytate content. Phytate is the compound in grains and legumes that binds minerals and reduces their absorption, so its near-absence in mycoprotein is a genuine advantage. That said, the chitin-rich fungal cell walls may themselves limit how much mineral the body can extract, and this is still being studied.⁴

Muscle Building and Protein Synthesis

One of the more striking findings in recent years is that mycoprotein appears to stimulate muscle protein synthesis at least as well as dairy. In a controlled trial with healthy young men, researchers compared the muscle-building response after consuming either mycoprotein or milk protein. Both sources increased muscle protein synthesis rates significantly, but the rise was roughly twice as large after mycoprotein ingestion. In exercised muscle specifically, protein synthesis rates climbed from baseline to about 0.072% per hour with mycoprotein versus about 0.056% per hour with milk.⁵

The researchers attributed this partly to the slower, more sustained amino acid release from mycoprotein, driven by the fiber matrix the protein is embedded in. Whey protein delivers a fast spike in blood amino acids; mycoprotein delivers a more gradual rise. For muscle-building purposes, both approaches stimulate synthesis, but the sustained delivery from mycoprotein seemed to produce a larger total response over the measurement period. This is a single study in young men, so it should not be treated as the final word, but it challenges the assumption that animal-derived proteins are always superior for muscle recovery.

Effects on Blood Cholesterol

The cholesterol-lowering effect of mycoprotein has been documented across multiple trials spanning decades. An early free-living study found that after eight weeks, people eating mycoprotein saw their total cholesterol drop by 0.95 mmol/L, roughly double the drop seen in the control group.⁶ More recent work has confirmed and refined this picture. A 2024 trial in overweight adults found that four weeks of incorporating mycoprotein-containing foods into the diet reduced total cholesterol by about 5%, LDL cholesterol by about 10%, and non-HDL cholesterol by about 6%, while a control group showed no change.⁷

The mechanism is thought to involve the beta-glucan and chitin fiber in mycoprotein binding bile acids in the gut, which forces the liver to pull cholesterol from the bloodstream to make more. HDL cholesterol and triglycerides were not affected in either study, so the benefit appears specific to LDL and total cholesterol. A 10% reduction in LDL is clinically meaningful and in the same range as what you would expect from dietary changes like increasing soluble fiber from oats or barley.

Blood Sugar, Insulin, and Appetite

The metabolic picture around blood sugar and appetite is more nuanced than the cholesterol data. In overweight and obese adults, mycoprotein meals reduced energy intake by about 10% compared to equivalent chicken meals, and produced lower insulin spikes (by 8% to 21% depending on the amount consumed), all without changing how quickly the stomach emptied or how much energy the body burned.⁸ The fiber content is the likely driver: it slows digestion, which blunts both the glucose and insulin peaks.

In people with type 2 diabetes, a trial found that mycoprotein reduced post-meal blood glucose by about 27% compared to chicken, an effect comparable to soy protein.⁹ However, in healthy adults eating mycoprotein alongside a mixed meal, blood glucose concentrations were not different from the control meal, though glucose handling at the cellular level did shift. The body appeared to route glucose differently without changing the overall blood sugar curve.¹⁰ So the blood sugar benefit may be most relevant for people whose glucose regulation is already impaired, rather than universally.

Gut Microbiome Effects

The gut health picture is still messy, frankly. Mycoprotein contains substantial fiber, and fiber generally feeds beneficial gut bacteria. But the two main in vitro fermentation studies that have been done reached different conclusions. One found that fermenting mycoprotein with human gut bacteria led to shifts in bacterial communities, enriching Bacteroides species and producing short-chain fatty acids (the metabolites that feed colon cells and reduce inflammation) at rates comparable to oat fiber over 72 hours.¹¹ The other found that pre-digested mycoprotein did not change microbial diversity or produce more short-chain fatty acids than a control.¹²

The disagreement likely comes down to methodology. The way the mycoprotein was prepared before being added to the bacterial cultures, whether it was pre-digested or not, and the duration of the experiment all affect what happens. Neither study was conducted in living humans, which is the real limitation. Until feeding trials with actual gut microbiome sampling are published, the prebiotic potential of mycoprotein remains an open question. The fiber is there, and its composition is unusual enough to be interesting, but the proof is not yet strong.

Environmental Footprint

This is where mycoprotein makes one of its strongest cases. A systematic review comparing mycoprotein-based meat alternatives to plant-based alternatives found that mycoprotein had lower greenhouse gas emissions per kilogram than soy protein concentrate or pea protein concentrate, coming in at about 0.73 kg CO₂-equivalent per kilogram compared to 1.21 for soy and 1.91 for pea.¹³ Finished mycoprotein-based products had emissions comparable to or lower than equivalent plant-based products, and well below any conventional meat.

Other analyses put mycoprotein’s emissions in a similar range, around 0.8 to 1.14 kg CO₂-equivalent per kilogram depending on the study and production setup, all dramatically lower than beef.¹⁴ A caveat comes from separate lifecycle analyses suggesting that simple pea and soy concentrates (as raw ingredients, not finished products) may have a lower footprint than mycoprotein in some studies, though data variability for those ingredients is large.¹⁵ The fermentation process does require energy and glucose feedstock, and the environmental math depends heavily on where that glucose comes from and how the facility is powered.

Land use is another advantage. Because mycoprotein is grown in bioreactors rather than fields, it uses a fraction of the land required for livestock and less than most crops per unit of protein produced. Water use is moderate: more than some dry-farmed pulses, but far less than beef or dairy. For someone trying to reduce the environmental footprint of their diet while maintaining a high protein intake, mycoprotein competes well against essentially every alternative, including most plant options.

Safety and Allergic Reactions

Mycoprotein is generally recognized as safe and has regulatory approval in the EU, UK, US, and many other markets. But it does provoke allergic reactions in a small subset of consumers, and this has been a point of controversy. An analysis of 1,752 self-reported adverse reactions to Quorn products found both allergic and gastrointestinal symptoms. Among the 312 people who reported allergic reactions (including hives and anaphylaxis), about 46% experienced symptoms within an hour of eating. One reaction was fatal.¹⁶

The allergy risk appears to be highest in people already sensitized to airborne mold allergens. A case study documented severe hypersensitivity in an asthmatic patient allergic to molds, identifying a specific fungal protein (acidic ribosomal protein P2) as the likely allergen. The proposed mechanism is that someone first becomes sensitized to mold proteins through their airways, and then eating mycoprotein introduces a cross-reactive protein through the gut, triggering a serious allergic response.¹⁷

For context, the number of reported reactions relative to the billions of servings sold globally is small. But if you have known mold allergies or a history of unexplained reactions to processed foods, it is worth knowing that mycoprotein is derived from a mold and could cross-react. Gastrointestinal symptoms like nausea and stomach cramps, without a true allergic mechanism, are also reported and may relate to the high fiber content or individual sensitivity to chitin.

On the toxicology side, there has been concern about whether Fusarium venenatum might produce mycotoxins (toxic compounds that some fungi generate). Safety testing has shown that the genes for mycotoxins like fumonisin remain unexpressed during fermentation, and toxins like zearalenone and deoxynivalenol cannot be detected in the growth medium.¹⁸ The controlled conditions of industrial fermentation, including temperature, pH, and substrate, are quite different from the natural environments where Fusarium species produce toxins on grain crops.

How Texture Is Engineered

Achieving a convincing meat-like texture from fungal biomass is an active area of food science. The fibrous hyphae of Fusarium venenatum provide a natural starting structure, but turning that structure into something that bites, tears, and chews like meat requires binding agents and precise processing. The traditional approach uses egg white protein (egg albumen), which adsorbs onto the surface of the hyphae through hydrogen bonding and electrostatic interactions, then forms a continuous gel when heated. As more egg white is added, the gel becomes denser and the texture properties improve, essentially filling in the spaces between mycelial strands.¹⁹

The reliance on egg white protein is one reason most Quorn products are not vegan (though a growing number now use potato starch or other plant-based binders instead). The egg white acts as a moderating agent: under different salt concentrations and pH conditions, gels made with egg white converge to similar firmness, which gives manufacturers more consistent results across processing batches.²⁰ Newer research is exploring alternatives. Coacervate binders made through liquid-liquid phase separation of proteins reduced cooking loss to about 22%, compared to about 29% for methylcellulose-based controls, while also producing firmer, chewier products.²¹

What Drives Consumer Adoption

Understanding who buys mycoprotein and why is relevant for predicting how the market evolves. A survey of over 4,000 respondents found that the strongest motivators for trying mycoprotein were perceived healthiness, nutritional benefits, safety, and sustainability, in roughly that order. Affordability and taste had mixed results, meaning they mattered to some people but not consistently across the sample. The biggest barrier was the nutritional importance consumers placed on meat: people who believed meat was essential to their diet were less willing to try mycoprotein, and to a lesser extent, people who valued the taste and texture of meat were also less interested.²²

Price remains a real obstacle. A techno-economic model estimated that building a mycoprotein production facility capable of producing 2,000 kilograms per hour requires roughly $108 million in capital, with the airlift bioreactor alone accounting for about two-thirds of that cost.²³ These capital requirements push retail prices above those of chicken or pork, though the model suggested that achieving price parity with beef protein is feasible at sufficient scale. As more competitors enter the space and production methods diversify, costs should come down, but mycoprotein is unlikely to undercut cheap plant proteins like lentils or chickpeas anytime soon.

Beyond Quorn and Fusarium

The next generation of mycoprotein research is moving beyond the single organism that built the industry. One project used co-cultures of fungi to bioconvert Durvillaea spp. (a brown seaweed) into a mycoprotein product, boosting the seaweed’s total protein content by roughly 238% and its amino acid profile by about 219% while also increasing beta-glucan levels. The resulting product showed prebiotic potential and contained unique bioactive compounds not found in the original seaweed.²⁴

Another approach uses Rhizopus microsporus var. oligosporus, the same fungus that makes tempeh, grown on agricultural byproducts like sugarcane molasses and corn steep liquor. A pilot-scale trial in airlift bioreactors achieved biomass yields of about 38 grams per liter after 96 hours, with crude protein making up roughly 70% of the dry mass. The researchers positioned this as a scalable, low-cost process primarily for animal feed, but the same organism and approach could potentially supply human food markets where the regulatory path is simpler.²⁵

These alternative strains and substrates matter because they decouple mycoprotein from a single species and a single feedstock. If production can run on waste streams from sugar or grain processing, the economics and environmental footprint both improve. And using different fungal species opens the door to different flavor profiles, textures, and nutritional compositions, potentially expanding mycoprotein from a niche meat substitute into a broader platform for food production.